NAD+ × peptide partners — lab test, July 2025
BioRegen publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone. Click 'Verify' (top right), then enter COA Number + Validation Key from the COA
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 500 mg · Lab measured 856 mg
171% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 214 mg using the measured mass, against 125 mg on the label — 71% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of NAD+ from peptide partners, performed by BioRegen on July 31, 2025. Reported purity: 99.76%. Net content: 856 mg against 500 mg labeled (171% of label). Tested content exceeds the labeled amount by 71%. Batch ND20250503. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of NAD+ from peptide partners
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| NBD202601 | 7 Feb 2026 | Kovera Labs | 99.856% | 116% | Unverified |
| NDU202601 | 20 Jan 2026 | Chromate | 99.851% | 86% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion